Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling

Journal of Clinical Investigation

Volumn 110, Issue 4, 2002, Pages 463-474

  Lanone, Sophie ^a   Zheng, Tao ^a   Zhu, Zhou ^a   Liu, Wei ^a   Lee, Chun Geun ^a   Ma, Bing ^a   Chen, Qingsheng ^a   Homer, Robert J ^a,b   Wang, Jingming ^a   Rabach, Lesley A ^a   Rabach, Morgan E ^a   Michael Shipley, J ^c   Shapiro, Steven D ^d   Senior, Robert M ^c   Elias, Jack A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 13; MACROPHAGE ELASTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME SPECIFICITY; INFLAMMATION; LUNG ALVEOLUS; LUNG COMPLIANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

EID: 0036679426     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214136     Document Type: Article

References (60)

1. Chronic obstructive pulmonary disease: Epidemiology, pathophysiology, and pathogenesis
2. Airway remodeling in asthma
3. Interstitial lung disease: A clinical overview and general approach
4. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients
5. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation
6. Increased matrix metalloproteinase-9 in the airway after allergen challenge
7. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics
8. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema
9. Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis
10. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD
11. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?
12. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias
13. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice
14. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metaloproteinase inhibitor batimastat
15. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model ofasthma
16. The role of IL-13 and its receptor in allergy and inflammatory responses
17. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes
18. Requirement for IL-13 independently of IL-4 in experimental asthma
19. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma
20. Interleukin-13: Central mediator of allergic asthma
21. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
22. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent
23. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung
24. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis
25. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema
26. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production
27. 1
28. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
29. Regulated overexpression of interleukin-11 in the lung: Use to dissociate development-dependent and -independent phenotypes
30. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin
31. Gamma interferon induction of pulmonary emphysema in the adult murine lung
32. Unsuspected pseudophysiologic emphysema in chronic persistent asthma
33. IL-13-induced chemokine responses in the lung: Role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling
34. Interleukin-13, an interleukin-4-like cycokine that acts on monocytes and B cells, but not on T cells
35. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13
36. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells
37. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
38. Interieukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts
39. How matrix metalloproteinases regulate cell behavior
40. The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo
41. The role of metalloelastase in immune complex-induced acute lung injury
42. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse
43. Generation of biologically active IL-1β by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1β processing
44. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact
45. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration
46. Inflammation dampened by gelatinase A cleavage of monocyte chemoattracrant protein-3
47. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
48. Elastic behavior of the lungs in patients
49. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation
50. Serum matrix metalloproteinase-9: Tissue inhibitor ofmetalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma
51. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
52. Chronic obstructive pulmonary disease
53. The many faces of airway inflammation: Asthma and chronic obstructive pulmonary disease
54. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis
55. Airway eosinophilia in chronic bronchitis during exacerbations
56. Update on the "Dutch hypothesis" for chronic respiratory disease
57. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth
58. Sputum metalloproteinase-9/tissue inhibitor ofmetalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis
59. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
60. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis